CNS leptin action modulates immune response and survival in sepsis

Johannes Tschop, Ruben Nogueiras, Sarah Kathleen Haas Lockie, Kevin R Kasten, Tamara R Castaneda, Nadine Huber, Kelsey Guanciale, Diego Perez-Tilve, Kirk Habegger, Nickki Ottaway, Stephen C Woods, Brian Oldfield, Iain Clarke, Streamson Chua Jr., I Sadaf Farooqi, Stephen O'Rahilly, Charles C Caldwell, Mathias H Tschop

Research output: Contribution to journalArticleResearchpeer-review

82 Citations (Scopus)

Abstract

Sepsis describes a complex clinical syndrome that results from an infection, setting off a cascade of systemic inflammatory responses that can lead to multiple organ failure and death. Leptin is a 16 kDa adipokine that, among its multiple known effects, is involved in regulating immune function. Here we demonstrate that leptin deficiency in ob/ob mice leads to higher mortality and more severe organ damage in a standard model of sepsis in mice [cecal ligation and puncture (CLP)]. Moreover, systemic leptin replacement improved the immune response to CLP. Based on the molecular mechanisms of leptin regulation of energy metabolism and reproductive function, we hypothesized that leptin acts in the CNS to efficiently coordinate peripheral immune defense in sepsis. We now report that leptin signaling in the brain increases survival during sepsis in leptin-deficient as well as in wild-type mice and that endogenous CNS leptin action is required for an adequate systemic immune response. These findings reveal the existence of a relevant neuroendocrine control of systemic immune defense and suggest a possible therapeutic potential for leptin analogs in infectious disease.
Original languageEnglish
Pages (from-to)6036 - 6047
Number of pages12
JournalThe Journal of Neuroscience
Volume30
Issue number17
DOIs
Publication statusPublished - 2010

Cite this